The Ayushman Bharat Digital Mission (ABDM) aims to replicate this success in healthcare delivery by building an equitable, accessible and inclusive ecosystem
New Director supports NASDAQ rule on diversity
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
Auld is a seasoned Financial Executive with over 30 years of relevant experience
Glofitamab has the potential to offer a readily available, fixed-duration CD20xCD3 bispecific antibody treatment approach for people with aggressive lymphoma
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
AKS-452 is currently undergoing Phase II/III clinical testing in India as a primary vaccine; submission for Emergency Use Authorization (EUA) expected by Q3 2022
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
Subscribe To Our Newsletter & Stay Updated
